Jing Huang

Extended peginterferon alfa‐2a (Pegasys) therapy in Chinese patients with HBeAg‐negative chronic hepatitis B

Xiao-Jun Ma, Xiaoping Chen, Xue-fu Chen, 2014, Journal of medical virology.

Alterations in Peripheral Lymphocyte Subsets in Early Stage of Novel Coronavirus Pneumonia

Yu Zhou, Xue-fu Chen, Jing Huang, 2020, SSRN Electronic Journal.

Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs

Ka Zhang, Wen-li Chen, Jing Huang, 2017, Scientific Reports.

Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression by MicroRNA-32 Promotes Proliferation and Epithelial-Mesenchymal Transition in Human Liver Cancer Cells.

Xiao-Jun Ma, Xiao-Jun Ma, Ren Chen, 2018, Oncology research.

Peripheral Circulating Exosomal-miRNAs Potentially Mediate the Sensitivity to Interferon Treatment in Chronic Hepatitis B Virus Patients.

Ying Wang, Linlin Lu, Yanfang Huang, 2023, Viral immunology.

Efficacy and safety of direct‐acting antiviral therapies and baseline predictors for treatment outcomes in hepatitis C patients: A multicenter, real‐world study in Guangdong, China

Y. Guan, K. Deng, Yuanping Zhou, 2022, Journal of medical virology.

[Study on the efficacy and HBeAg seroconversion related factors of telbivudine and entecavir therapy in HBeAg positive chronic hepatitis B patients].

Xiao-Jun Ma, Xue-fu Chen, Xiao-ping Chen, 2011, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs

Ka Zhang, Wen-li Chen, Jing Huang, 2017, Scientific Reports.